# loteprednol etabonate

NDC: 60219-1366
Generic name: loteprednol etabonate
Labeler / Manufacturer: Amneal Pharmaceuticals NY LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION/ DROPS
Routes: OPHTHALMIC
Marketing started: 20241218

FDA application: ANDA216345

## Active ingredients

- LOTEPREDNOL ETABONATE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60219-1366"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60219-1366
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3c2e7083-6ba1-4131-a23f-462b02e5c036